FY2026 Earnings Forecast for Clorox Issued By Zacks Research

The Clorox Company (NYSE:CLX) – Equities researchers at Zacks Research reduced their FY2026 earnings per share estimates for shares of Clorox in a research note issued on Thursday, May 14th. Zacks Research analyst Team now expects that the company will earn $5.50 per share for the year, down from their prior forecast of $5.95. Zacks Research has a “Strong Sell” rating on the stock. The consensus estimate for Clorox’s current full-year earnings is $5.63 per share. Zacks Research also issued estimates for Clorox’s Q4 2026 earnings at $1.62 EPS, Q1 2027 earnings at $1.28 EPS, Q2 2027 earnings at $1.44 EPS, Q3 2027 earnings at $1.57 EPS, Q4 2027 earnings at $1.71 EPS, FY2027 earnings at $6.00 EPS, Q1 2028 earnings at $1.28 EPS, Q2 2028 earnings at $1.59 EPS, Q3 2028 earnings at $1.76 EPS and FY2028 earnings at $6.36 EPS.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the prior year, the firm posted $1.45 EPS. The company’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS.

A number of other research analysts have also commented on the company. Evercore reaffirmed an “underperform” rating and issued a $110.00 price objective on shares of Clorox in a report on Friday, May 1st. Jefferies Financial Group cut their target price on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Wall Street Zen upgraded Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Morgan Stanley cut their target price on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. Finally, UBS Group cut their target price on Clorox from $110.00 to $96.00 and set a “neutral” rating for the company in a research report on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Reduce” and a consensus price target of $103.40.

Clorox Stock Performance

Shares of NYSE CLX opened at $92.84 on Tuesday. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The stock’s fifty day moving average price is $101.58 and its two-hundred day moving average price is $106.75. Clorox has a one year low of $84.70 and a one year high of $136.69. The firm has a market cap of $11.23 billion, a price-to-earnings ratio of 15.07, a P/E/G ratio of 0.47 and a beta of 0.59.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, May 8th. Stockholders of record on Wednesday, April 22nd were given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 5.3%. The ex-dividend date was Wednesday, April 22nd. Clorox’s dividend payout ratio is presently 80.52%.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber bought 5,000 shares of the business’s stock in a transaction dated Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director owned 18,000 shares in the company, valued at $1,544,760. The trade was a 38.46% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.63% of the company’s stock.

Hedge Funds Weigh In On Clorox

A number of institutional investors have recently modified their holdings of CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Clorox by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after buying an additional 514 shares in the last quarter. Woodline Partners LP raised its holdings in shares of Clorox by 253.7% during the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock worth $1,532,000 after buying an additional 7,465 shares in the last quarter. Baird Financial Group Inc. raised its holdings in shares of Clorox by 1.7% during the 2nd quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after buying an additional 424 shares in the last quarter. Jump Financial LLC raised its holdings in shares of Clorox by 173.5% during the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock worth $1,500,000 after buying an additional 7,924 shares in the last quarter. Finally, Bank of Nova Scotia raised its holdings in shares of Clorox by 26.2% during the 2nd quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock worth $1,938,000 after buying an additional 3,352 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox News Summary

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: MarketWatch noted Clorox stock outperformed peers in a strong trading session, suggesting investors are still rotating toward the name when sentiment improves. Clorox Co. stock outperforms competitors on strong trading day
• Neutral Sentiment: Wells Fargo cut its price target on Clorox to $95 from $100 while keeping an equal-weight rating, signaling caution but still implying limited upside from current levels. Clorox (NYSE:CLX) Price Target Cut to $95.00 by Analysts at Wells Fargo & Company
• Negative Sentiment: Zacks Research lowered its FY2026 earnings estimate for Clorox to $5.50 per share from $5.95, reflecting softer near-term profit expectations.
• Negative Sentiment: The firm also cut FY2027 earnings to $6.00 from $6.74, FY2028 to $6.36 from $7.23, and trimmed multiple quarterly forecasts, including Q4 2026, Q1 2027, Q2 2027, and Q4 2027.
• Negative Sentiment: Zacks Research maintained a “Strong Sell” rating, reinforcing bearish sentiment around Clorox (NYSE:CLX) despite its stable consumer-staples profile.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.